Bertram Müller-Myhsok

City:

Munchen

Country:

Germany

Published Applications:

Last publication date:

2016-03-10

Top Assignees for applications by Bertram Müller-Myhsok

The entities that hold a legal rights for patent applications filed by inventor Müller-Myhsok Bertram:

Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. 1 Munchen, Germany
Max-Planck-Gesellschaft zur Foerderung der Wissenschaften E. V. 1 Munich, Germany
Max-Planck-Gesellschaft zur Förderung der Wisenschaften e. V. 1 Munchen, Germany
Max-Planck-Gesellschaft zur Forderung der Wissensc 1 Berlin, Germany
Max-Planck-Gesellschaft zur Forderung der Wissenschaften E.V. 1 , Germany
Max-Planck-Gesellschaft zur Förderung der Wisenschaften e.V. 1 Munich, Germany

Recent patent applications by Müller-Myhsok Bertram

Bertram Müller-Myhsok from Munchen, DE has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2016-03-10

US20160067262A1

Human necessities

Polymorphisms in ABCB1 associated with a lack of clinical response to medicaments

#2 | 2015-10-01

US20150278438A1

Physics

GENETIC PREDICTORS OF RESPONSE TO TREATMENT WITH CRHR1 ANTAGONISTS

#3 | 2013-09-26

US20130252822A1

Chemistry; metallurgy

Methods for Predicting an Antibody Response to Interferon Therapy in Multiple Sclerosis Patients

#4 | 2010-08-12

US20100202972A1

Chemistry; metallurgy

USE OF GENE VARIANTS OF THE HUMAN MEIS1, BTBD9, MAP2K5, LBXCOR1, PTPRD OR A2BP1 GENE FOR DIAGNOSTIC AND THERAPEUTIC APPROACHES TO RESTLESS LEGS SYNDROME (RLS)

#5 | 2010-07-22

US20100184742A1

Human necessities

Polymorphisms in ABCB1 associated with a lack of clinical response to medicaments

#6 | 2009-07-23

US20090186773A1

Chemistry; metallurgy

Methods for predicting the response of multiple sclerosis patients to interferon therapy and diagnosing multiple sclerosis

#7 | 2007-12-27

US20070298027A1

Chemistry; metallurgy

Novel Target for Antiderpressant Therapy

InventorID:

456900 ⎘